PubRank

Robert H Perry

Author PubWeight™ 53.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006 6.52
2 Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 2006 4.24
3 A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011 4.15
4 Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol 2003 2.61
5 The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 2006 2.42
6 Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol 2009 2.21
7 Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 2002 1.88
8 Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. Am J Psychiatry 2004 1.82
9 Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 2005 1.62
10 alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol 2004 1.53
11 alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases. Acta Neuropathol 2004 1.43
12 Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 2010 1.31
13 Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003 1.27
14 The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol 2011 1.18
15 Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2007 1.16
16 Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis 2006 1.06
17 Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID). Neurobiol Aging 2005 1.04
18 Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis 2012 0.98
19 Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behav Brain Res 2005 0.93
20 Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2002 0.93
21 Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet 2005 0.92
22 Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia. Neurobiol Aging 2011 0.91
23 FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy. J Mol Neurosci 2011 0.88
24 The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease. Acta Neuropathol 2010 0.87
25 Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. J Neuropathol Exp Neurol 2013 0.86
26 Neurochemistry of consciousness: cholinergic pathologies in the human brain. Prog Brain Res 2004 0.86
27 Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease. J Chem Neuroanat 2003 0.85
28 Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. Int J Neuropsychopharmacol 2006 0.83
29 Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. J Neurol Sci 2004 0.82
30 Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiol Aging 2006 0.81
31 Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies. Hippocampus 2010 0.81
32 Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies. Neuropathology 2011 0.79
33 Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse 2007 0.79
34 Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dement Geriatr Cogn Disord 2008 0.79
35 Increased neural progenitors in vascular dementia. Neurobiol Aging 2010 0.79
36 Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients. Neurosci Lett 2008 0.77
37 Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID). J Neural Transm (Vienna) 2011 0.77